Suboptimal Therapy of Heart Failure: A Continuing Theme
نویسندگان
چکیده
منابع مشابه
Diuretic usage in heart failure: a continuing conundrum in 2005.
Several large well-designed clinical trials have shown that the use of diuretics is beneficial in patients with hypertension. However, similarly robust data regarding their role in chronic heart failure are lacking. Historically, diuretics were developed for treatment of sodium and water retention in oedematous disorders and clinically, they remain the most potent drugs available to relieve sym...
متن کاملMicroRNA therapy of heart failure
MicroRNAs (miRNAs) are short, noncoding RNAs that have revolutionized the way we interpret genetic regulation. A component of what was once considered junk DNA, miRNAs regulate virtually every protein-coding gene in a highly dynamic fashion. Growing evidence has indicated that miRNAs are centrally involved in the pathogenesis of heart failure and strategies to modulate their activity therapeuti...
متن کاملCONGESTIVE HEART FAILURE IN CHILDREN: A SURVEY OF 114 PATIENTS
During a period of four years between June, IS, 1988 to June, IS, 1992 one hundred and fourteen patients with congestive heart failure (CHF) were admitted to the pediatric department of Taleghani General Hospital. During the above period, 192 patients with heart disease were hospitalized at this department and CHF was the cause of admission in 59.4% of them. Congenital heart disease (CHO) w...
متن کاملMetabolic therapy for heart failure including diastolic heart failure
Cardiac energetic impairment is a feature of systolic heart failure irrespective of the underlying etiology, and the magnitude of this impairment is predictive of subsequent mortality. It is also a feature of other forms of heart muscle diseases including hypertrophic cardiomyopathy and heart failure with normal ejection fraction. While the adult heart normally uses predominantly free fatty aci...
متن کاملGene therapy in heart failure.
With increasing knowledge of basic molecular mechanisms governing the development of heart failure (HF), the possibility of specifically targeting key pathological players is evolving. Technology allowing for efficient in vivo transduction of myocardial tissue with long-term expression of a transgene enables translation of basic mechanistic knowledge into potential gene therapy approaches. Gene...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Preventive Cardiology
سال: 2004
ISSN: 1520-037X,1751-7141
DOI: 10.1111/j.1520-037x.2004.02884.x